ScienceDex / Researcher record
David W. Goodrich
- Thomas Jefferson University · Pharmacology (NIH department code)
- Roswell Park Comprehensive Cancer Center (no department on record)
From the FY2026 NIH awards this investigator leads as contact PI. The department is the award's.
- Program Leader
- R01 Holder
- Early Career
- Diverse Portfolio
NIH Funding · FY2026
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2024 | $2,127,430 | 3 | #4,802 |
| 2025 | $1,832,533 | 1 | #7,642 |
| 2026 | $4,302,647 | 3 | #3,649 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20243 records
- FY20251 record
- FY2026 · selected3 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 1898849Search this ID in NIH RePORTER
- ORCID iD
- https://orcid.org/0000-0002-1021-1827Verified identifier for this researcher
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.
FY2026 award categories
- Pharmacology
FY2026 award records by amount
NIH award records listing David W. Goodrich as a PI. Multi-PI records show the full award amount for context.
- 5U24CA274159-05U24Co-investigatorCoordinating and Data Management Center for Acquired Resistance to Therapy Network$1.9Maward amount
- 1P01CA298993-01A1P01Contact PINeuroendocrine Prostate Cancer Progression and Novel Therapeutic VulnerabilitiesThomas Jefferson University · Pharmacology (NIH department code)$1.7Maward amount
- 1R01CA305978-01A1R01Contact PIElucidating mechanisms underlying lung cancer lineage plasticity thatfacilitate adaptation and resistance to targeted therapy$720Kaward amount
Award organizations
Organizations that administered FY2026 awards listing David W. Goodrich as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardRoswell Park Comprehensive Cancer Center
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #4802
- 2024Entered Top 25% NationallyRanked #4802
- 2025Multi-Institutional ResearchAwards at 2 institutions
- 2025R01 Grant Holder
- 2025Program/Center Grant Leader
- 2026$5M Cumulative Funding
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as David W. Goodrich.